Despite multiple therapeutic approaches, including DA, multiple surgical resections, TMZ, tyrosine kinase inhibitor (TKI), and anti-PD-L1 therapy, the tumor progression continued to fluctuate. This evidence concerns the gene CD274 and neoplasm.